Exponent Inc EXPO
We take great care to ensure that the data presented and summarized in this overview for EXPONENT INC is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding EXPO
View all-
Black Rock Inc. New York, NY5.99MShares$446 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.27MShares$392 Million0.01% of portfolio
-
Kayne Anderson Rudnick Investment Management LLC Los Angeles, CA4.79MShares$357 Million0.99% of portfolio
-
Conestoga Capital Advisors, LLC2.78MShares$207 Million3.39% of portfolio
-
State Street Corp Boston, MA1.93MShares$143 Million0.01% of portfolio
-
Neuberger Berman Group LLC New York, NY1.85MShares$138 Million0.13% of portfolio
-
Geneva Capital Management LLC1.75MShares$130 Million2.68% of portfolio
-
Geode Capital Management, LLC Boston, MA1.58MShares$117 Million0.01% of portfolio
-
Dimensional Fund Advisors LP Austin, TX897KShares$66.8 Million0.02% of portfolio
-
Terry Smith Fundsmith LLP | London, X0836KShares$62.3 Million0.31% of portfolio
Latest Institutional Activity in EXPO
Top Purchases
Top Sells
About EXPO
Exponent, Inc., together with its subsidiaries, operates as a science and engineering consulting company worldwide. It operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering. The Environmental and Health segment offers services in the areas of chemical regulation and food safety, ecological and biological sciences, environmental and earth sciences, and health sciences. The company offers approximately 90 technical disciplines to solve pressing and complicated challenges facing stakeholders. It serves clients in chemical, construction, consumer products, energy, food, beverage and nutrition, government, life sciences, insurance, manufacturing, technology, industrial equipment, transportation, and other sectors of the economy. The company was formerly known as The Failure Group, Inc. and changed its name to Exponent, Inc. in 1998. Exponent, Inc. was founded in 1967 and is headquartered in Menlo Park, California.
Insider Transactions at EXPO
Insider Transaction List
View allDate | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Jun 04
2025
|
Carol Lindstrom Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,525
+17.09%
|
-
|
Jun 04
2025
|
Debra Zumwalt Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,525
+4.87%
|
-
|
Jun 04
2025
|
Paul R Johnston Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,525
+2.44%
|
-
|
Jun 04
2025
|
George H. Brown Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,525
+14.88%
|
-
|
Jun 04
2025
|
Karen A Richardson Director |
BUY
Exercise of conversion of derivative security
|
Indirect |
1,525
+4.52%
|
-
|
May 27
2025
|
Joseph Rakow Group Vice President |
SELL
Open market or private sale
|
Direct |
1,573
-100.0%
|
$121,121
$77.72 P/Share
|
May 23
2025
|
John Pye Group Vice President |
SELL
Open market or private sale
|
Direct |
2,000
-3.23%
|
$152,000
$76.32 P/Share
|
May 20
2025
|
Bradley A James Group Vice President |
SELL
Open market or private sale
|
Direct |
2,694
-100.0%
|
$212,826
$79.52 P/Share
|
Mar 12
2025
|
Catherine Corrigan President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
3,625
-4.27%
|
$297,250
$82.33 P/Share
|
Mar 12
2025
|
Catherine Corrigan President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
8,090
+8.69%
|
-
|
Mar 12
2025
|
Bradley A James Group Vice President |
SELL
Payment of exercise price or tax liability
|
Direct |
1,352
-33.42%
|
$110,864
$82.33 P/Share
|
Mar 12
2025
|
Bradley A James Group Vice President |
BUY
Exercise of conversion of derivative security
|
Direct |
4,046
+50.0%
|
-
|
Mar 12
2025
|
John Pye Group Vice President |
SELL
Payment of exercise price or tax liability
|
Direct |
866
-2.7%
|
$71,012
$82.33 P/Share
|
Mar 12
2025
|
John Pye Group Vice President |
BUY
Exercise of conversion of derivative security
|
Direct |
3,438
+9.68%
|
-
|
Mar 12
2025
|
Joseph Rakow Group Vice President |
SELL
Payment of exercise price or tax liability
|
Direct |
1,159
-42.42%
|
$95,038
$82.33 P/Share
|
Mar 12
2025
|
Joseph Rakow Group Vice President |
BUY
Exercise of conversion of derivative security
|
Direct |
2,732
+50.0%
|
-
|
Mar 12
2025
|
Richard Reiss Group Vice President |
SELL
Payment of exercise price or tax liability
|
Direct |
824
-22.75%
|
$67,568
$82.33 P/Share
|
Mar 12
2025
|
Richard Reiss Group Vice President |
BUY
Exercise of conversion of derivative security
|
Direct |
1,822
+33.47%
|
-
|
Mar 12
2025
|
Maureen T. F. Reitman Group Vice President |
SELL
Payment of exercise price or tax liability
|
Direct |
1,190
-3.23%
|
$97,580
$82.33 P/Share
|
Mar 12
2025
|
Maureen T. F. Reitman Group Vice President |
BUY
Exercise of conversion of derivative security
|
Direct |
3,844
+9.46%
|
-
|
Last 12 Months Summary
Exercise of conversion of derivative security | 109K shares |
---|
Bona fide gift | 34.5K shares |
---|---|
Payment of exercise price or tax liability | 12.7K shares |
Open market or private sale | 151K shares |